Ransohoff JD[Author] - Search Results

Year	Number of Results
2012	1
2013	2
2014	1
2015	1
2016	1
2017	3
2018	3
2019	2
2020	1
2023	1
2024	1

1

The functions and unique features of long intergenic non-coding RNA.

Ransohoff JD, Wei Y, Khavari PA. Ransohoff JD, et al. Nat Rev Mol Cell Biol. 2018 Mar;19(3):143-157. doi: 10.1038/nrm.2017.104. Epub 2017 Nov 15. Nat Rev Mol Cell Biol. 2018. PMID: 29138516 Free PMC article. Review.

2

Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer.

Ransohoff JD, Ritter V, Purington N, Andrade K, Han S, Liu M, Liang SY, John EM, Gomez SL, Telli ML, Schapira L, Itakura H, Sledge GW, Bhatt AS, Kurian AW. Ransohoff JD, et al. Nat Commun. 2023 Apr 12;14(1):2053. doi: 10.1038/s41467-023-37636-0. Nat Commun. 2023. PMID: 37045824 Free PMC article.

3

Tracking gene and cell fate for therapeutic gain.

Kooreman NG, Ransohoff JD, Wu JC. Kooreman NG, et al. Among authors: ransohoff jd. Nat Mater. 2014 Feb;13(2):106-9. doi: 10.1038/nmat3868. Nat Mater. 2014. PMID: 24452344 Free PMC article. Review.

4

Cutaneous Adverse Events of Targeted Therapies for Hematolymphoid Malignancies.

Ransohoff JD, Kwong BY. Ransohoff JD, et al. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):834-851. doi: 10.1016/j.clml.2017.07.005. Epub 2017 Jul 14. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28918995 Review.

5

Immunogenicity of pluripotent stem cells and their derivatives.

de Almeida PE, Ransohoff JD, Nahid A, Wu JC. de Almeida PE, et al. Among authors: ransohoff jd. Circ Res. 2013 Feb 1;112(3):549-61. doi: 10.1161/CIRCRESAHA.111.249243. Circ Res. 2013. PMID: 23371903 Free PMC article. Review.

6

Imaging stem cell therapy for the treatment of peripheral arterial disease.

Ransohoff JD, Wu JC. Ransohoff JD, et al. Curr Vasc Pharmacol. 2012 May;10(3):361-73. doi: 10.2174/157016112799959404. Curr Vasc Pharmacol. 2012. PMID: 22239638 Free PMC article. Review.

7

Profiling off-label prescriptions in cancer treatment using social health networks.

Nikfarjam A, Ransohoff JD, Callahan A, Polony V, Shah NH. Nikfarjam A, et al. Among authors: ransohoff jd. JAMIA Open. 2019 Oct;2(3):301-305. doi: 10.1093/jamiaopen/ooz025. Epub 2019 Jul 22. JAMIA Open. 2019. PMID: 31709388 Free PMC article.

8

Detecting Chemotherapeutic Skin Adverse Reactions in Social Health Networks Using Deep Learning.

Ransohoff JD, Nikfarjam A, Jones E, Loew B, Kwong BY, Sarin KY, Shah NH. Ransohoff JD, et al. JAMA Oncol. 2018 Apr 1;4(4):581-583. doi: 10.1001/jamaoncol.2017.5688. JAMA Oncol. 2018. PMID: 29494731 Free PMC article.

9

Assessment of Accuracy of Patient-Initiated Differential Diagnosis Generation by Google Reverse Image Searching.

Ransohoff JD, Li S, Sarin KY. Ransohoff JD, et al. JAMA Dermatol. 2016 Oct 1;152(10):1164-1166. doi: 10.1001/jamadermatol.2016.2096. JAMA Dermatol. 2016. PMID: 27367170 No abstract available.

10

CALML5 is a ZNF750- and TINCR-induced protein that binds stratifin to regulate epidermal differentiation.

Sun BK, Boxer LD, Ransohoff JD, Siprashvili Z, Qu K, Lopez-Pajares V, Hollmig ST, Khavari PA. Sun BK, et al. Among authors: ransohoff jd. Genes Dev. 2015 Nov 1;29(21):2225-30. doi: 10.1101/gad.267708.115. Genes Dev. 2015. PMID: 26545810 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

16 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year